Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 06, 2019

SELL
$219.29 - $241.72 $1.88 Million - $2.07 Million
-8,579 Closed
0 $0
Q1 2019

May 03, 2019

BUY
$216.71 - $338.96 $120,490 - $188,461
556 Added 6.93%
8,579 $2.03 Million
Q4 2018

Feb 12, 2019

BUY
$278.5 - $352.75 $2.23 Million - $2.83 Million
8,023 New
8,023 $2.41 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Hamilton Wealth, LLC Portfolio

Follow Hamilton Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Wealth, LLC with notifications on news.